Dr antonio pea

Institute of Cancer Sciences (School of Cancer Sciences)

email: Antonio.Pea@glasgow.ac.uk

University of Verona, Verona, 37131

Import to contacts

Publications

List by: Type | Date

Jump to: 2024 | 2023 | 2021

Number of items: 5.

2024

O’Rourke, C. J. et al. (2024) Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy. Gut, 73(3), pp. 496-508. (doi: 10.1136/gutjnl-2023-330748) (PMID:37758326) (PMCID:PMC10894814)

2023

Dreyer, S. B. et al. (2023) The impact of molecular subtyping on pathological staging of pancreatic cancer. Annals of Surgery, 277(2), e396-e405. (doi: 10.1097/SLA.0000000000005050) (PMID:36745763) (PMCID:PMC9831035)

2021

Casolino, R. et al. (2021) Homologous recombination deficiency in pancreatic cancer: a systematic review and prevalence meta-analysis. Journal of Clinical Oncology, 39(23), pp. 2617-2631. (doi: 10.1200/JCO.20.03238) (PMID:34197182) (PMCID:PMC8331063)

Froeling, Fieke E.M. ORCID: https://orcid.org/0000-0002-8653-8164, Casolino, Raffaella, Pea, Antonio, Biankin, Andrew V. ORCID: https://orcid.org/0000-0002-0362-5597 and Chang, David K. ORCID: https://orcid.org/0000-0002-4821-3078 (2021) Molecular subtyping and precision medicine for pancreatic cancer. Journal of Clinical Medicine, 10(1), 149. (doi: 10.3390/jcm10010149) (PMID:33406790) (PMCID:PMC7794969)

Pea, Antonio, Jamieson, Nigel B. ORCID: https://orcid.org/0000-0002-9552-4725 and Braconi, Chiara ORCID: https://orcid.org/0000-0003-4835-1259 (2021) Biology and clinical application of regulatory RNAs in hepatocellular carcinoma. Hepatology, 73(S1), pp. 38-48. (doi: 10.1002/hep.31225) (PMID:32160335)

This list was generated on Thu Jun 19 05:21:45 2025 BST.

Jump to: Articles

Number of items: 5.

Articles

O’Rourke, C. J. et al. (2024) Molecular portraits of patients with intrahepatic cholangiocarcinoma who diverge as rapid progressors or long survivors on chemotherapy. Gut, 73(3), pp. 496-508. (doi: 10.1136/gutjnl-2023-330748) (PMID:37758326) (PMCID:PMC10894814)

Dreyer, S. B. et al. (2023) The impact of molecular subtyping on pathological staging of pancreatic cancer. Annals of Surgery, 277(2), e396-e405. (doi: 10.1097/SLA.0000000000005050) (PMID:36745763) (PMCID:PMC9831035)

Casolino, R. et al. (2021) Homologous recombination deficiency in pancreatic cancer: a systematic review and prevalence meta-analysis. Journal of Clinical Oncology, 39(23), pp. 2617-2631. (doi: 10.1200/JCO.20.03238) (PMID:34197182) (PMCID:PMC8331063)

Froeling, Fieke E.M. ORCID: https://orcid.org/0000-0002-8653-8164, Casolino, Raffaella, Pea, Antonio, Biankin, Andrew V. ORCID: https://orcid.org/0000-0002-0362-5597 and Chang, David K. ORCID: https://orcid.org/0000-0002-4821-3078 (2021) Molecular subtyping and precision medicine for pancreatic cancer. Journal of Clinical Medicine, 10(1), 149. (doi: 10.3390/jcm10010149) (PMID:33406790) (PMCID:PMC7794969)

Pea, Antonio, Jamieson, Nigel B. ORCID: https://orcid.org/0000-0002-9552-4725 and Braconi, Chiara ORCID: https://orcid.org/0000-0003-4835-1259 (2021) Biology and clinical application of regulatory RNAs in hepatocellular carcinoma. Hepatology, 73(S1), pp. 38-48. (doi: 10.1002/hep.31225) (PMID:32160335)

This list was generated on Thu Jun 19 05:21:45 2025 BST.